A couple weeks ago, we learned that pharma giant Allergan had transferred title to its most profitable eye drugs to New York's St Regis Mohawk band in order to invoke the band's "sovereign immunity" in proceedings that sought to invalidate its patents and make its drugs universally available at low costs. (more…)
